GRCh38/hg38 1q21.1-21.2(chr1:146964168-148572213)x3 AND See cases

Germline classification:: Pathogenic (1 submission)
Last evaluated:: Jul 22, 2013
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000143533.5

Allele description [Variation Report for GRCh38/hg38 1q21.1-21.2(chr1:146964168-148572213)x3]

GRCh38/hg38 1q21.1-21.2(chr1:146964168-148572213)x3

Genes:

LOC129931358:ATAC-STARR-seq lymphoblastoid active region 1635 [Gene]
LOC129931359:ATAC-STARR-seq lymphoblastoid active region 1637 [Gene]
LOC129931360:ATAC-STARR-seq lymphoblastoid active region 1638 [Gene]
LOC129931361:ATAC-STARR-seq lymphoblastoid active region 1639 [Gene]
LOC129931362:ATAC-STARR-seq lymphoblastoid active region 1640 [Gene]
LOC129931363:ATAC-STARR-seq lymphoblastoid active region 1641 [Gene]
LOC129931364:ATAC-STARR-seq lymphoblastoid active region 1648 [Gene]
LOC129931366:ATAC-STARR-seq lymphoblastoid active region 1649 [Gene]
LOC129931352:ATAC-STARR-seq lymphoblastoid silent region 1277 [Gene]
LOC129931353:ATAC-STARR-seq lymphoblastoid silent region 1278 [Gene]
LOC129931354:ATAC-STARR-seq lymphoblastoid silent region 1279 [Gene]
LOC129931355:ATAC-STARR-seq lymphoblastoid silent region 1280 [Gene]
LOC129931356:ATAC-STARR-seq lymphoblastoid silent region 1281 [Gene]
LOC129931357:ATAC-STARR-seq lymphoblastoid silent region 1282 [Gene]
LOC129931365:ATAC-STARR-seq lymphoblastoid silent region 1286 [Gene]
LOC129931367:ATAC-STARR-seq lymphoblastoid silent region 1287 [Gene]
BCL9:BCL9 transcription coactivator [Gene - OMIM - HGNC]
LOC126805854:BRD4-independent group 4 enhancer GRCh37_chr1:146764440-146765639 [Gene]
LOC126805852:CDK7 strongly-dependent group 2 enhancer GRCh37_chr1:146501494-146502693 [Gene]
GPR89B:G protein-coupled receptor 89B [Gene - OMIM - HGNC]
LOC111556113:HNF4 motif-containing MPRA enhancer 9 [Gene]
LOC129388602:MPRA-validated peak400 silencer [Gene]
LOC129388603:MPRA-validated peak402 silencer [Gene]
LOC129388604:MPRA-validated peak403 silencer [Gene]
NBPF11:NBPF member 11 [Gene - OMIM - HGNC]
NBPF12:NBPF member 12 [Gene - OMIM - HGNC]
NBPF14:NBPF member 14 [Gene - OMIM - HGNC]
LOC126805853:P300/CBP strongly-dependent group 1 enhancer GRCh37_chr1:146633127-146634326 [Gene]
RNVU1-1:RNA, variant U1 small nuclear 1 [Gene - HGNC]
RNVU1-27:RNA, variant U1 small nuclear 27 [Gene - HGNC]
RNVU1-3:RNA, variant U1 small nuclear 3 [Gene - HGNC]
RNVU1-7:RNA, variant U1 small nuclear 7 [Gene - HGNC]
RNVU1-8:RNA, variant U1 small nuclear 8 [Gene - HGNC]
LOC121725052:Sharpr-MPRA regulatory region 10305 [Gene]
LOC122128420:Sharpr-MPRA regulatory region 3144 [Gene]
LOC112577490:Sharpr-MPRA regulatory region 3868 [Gene]
LOC121725051:Sharpr-MPRA regulatory region 5908 [Gene]
LOC121725053:Sharpr-MPRA regulatory region 879 [Gene]
LOC110121261:VISTA enhancer hs2126 [Gene]
ACP6:acid phosphatase 6, lysophosphatidic [Gene - OMIM - HGNC]
CHD1L:chromodomain helicase DNA binding protein 1 like [Gene - OMIM - HGNC]
FMO5:flavin containing dimethylaniline monoxygenase 5 [Gene - OMIM - HGNC]
GJA5:gap junction protein alpha 5 [Gene - OMIM - HGNC]
GJA8:gap junction protein alpha 8 [Gene - OMIM - HGNC]
LINC01138:long intergenic non-protein coding RNA 1138 [Gene - HGNC]
LINC01731:long intergenic non-protein coding RNA 1731 [Gene - HGNC]
LINC02805:long intergenic non-protein coding RNA 2805 [Gene - HGNC]
LINC02806:long intergenic non-protein coding RNA 2806 [Gene - HGNC]
LINC00624:long intergenic non-protein coding RNA 624 [Gene - HGNC]
MIR5087:microRNA 5087 [Gene - HGNC]
MIR6077:microRNA 6077 [Gene - HGNC]
PPIAL4G:peptidylprolyl isomerase A like 4G [Gene - HGNC]
PRKAB2:protein kinase AMP-activated non-catalytic subunit beta 2 [Gene - OMIM - HGNC]
TRN-GTT2-1:tRNA-Asn (anticodon GTT) 2-1 [Gene - HGNC]
TRN-GTT9-2:tRNA-Asn (anticodon GTT) 9-2 [Gene - HGNC]
TRQ-CTG3-2:tRNA-Gln (anticodon CTG) 3-2 [Gene - HGNC]
TRQ-CTG4-1:tRNA-Gln (anticodon CTG) 4-1 [Gene - HGNC]
TRQ-CTG7-1:tRNA-Gln (anticodon CTG) 7-1 [Gene - HGNC]
TRH-GTG1-2:tRNA-His (anticodon GTG) 1-2 [Gene - HGNC]
TRH-GTG1-3:tRNA-His (anticodon GTG) 1-3 [Gene - HGNC]
TRH-GTG1-4:tRNA-His (anticodon GTG) 1-4 [Gene - HGNC]
LOC101927468:uncharacterized LOC101927468 [Gene]
LOC128071544:uncharacterized LOC128071544 [Gene]

Variant type:

copy number gain

Cytogenetic location:

1q21.1-21.2

Genomic location:

Preferred name:

GRCh38/hg38 1q21.1-21.2(chr1:146964168-148572213)x3

HGVS:

NC_000001.11:g.(?_146964168)_(148572213_?)dup
NC_000001.10:g.(?_145895747)_(147831170_?)dup

Links:

dbVar: nssv3397225; dbVar: nsv995619

Observations:

Condition(s)

Name:: See cases [See the Variation display for details]
Identifiers:

Recent activity

Clear Turn Off Turn On

PREDICTED: phospholipase A2, membrane associated [Colobus angolensis palliatus]
PREDICTED: phospholipase A2, membrane associated [Colobus angolensis palliatus]
gi|795125161|ref|XP_011789395.1|

Protein
Betazole
Betazole
A histamine H2 agonist used clinically to test gastric secretory function.<br/>Year introduced: 1991(1975)

MeSH
LINC01597 long intergenic non-protein coding RNA 1597 [Homo sapiens]
LINC01597 long intergenic non-protein coding RNA 1597 [Homo sapiens]
Gene ID:400841

Gene

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000183045	ISCA site 1 See additional submitters International Standards For Cytogenomic Arrays Consortium (ISCA)	no assertion criteria provided	Pathogenic (Jul 22, 2013)	unknown	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000183045

ISCA site 1

See additional submitters

no assertion criteria provided

Pathogenic
(Jul 22, 2013)

unknown

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
human	not provided	yes	1	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, Church DM, Crolla JA, Eichler EE, Epstein CJ, Faucett WA, Feuk L, Friedman JM, Hamosh A, Jackson L, Kaminsky EB, Kok K, Krantz ID, Kuhn RM, Lee C, Ostell JM, Rosenberg C, et al.

Am J Hum Genet. 2010 May 14;86(5):749-64. doi: 10.1016/j.ajhg.2010.04.006. Review.

PubMed [citation]

PMID:: 20466091
PMCID:: PMC2869000

Details of each submission

From ISCA site 1, SCV000183045.4

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	human	1	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	yes	not provided	not provided	Discovery		1	not provided	not provided	not provided

Last Updated: May 7, 2024

ClinVar

Relating variation to medicine